April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
SS- OCT analysis of choroidal involvement in patients with uveitis
Author Affiliations & Notes
  • Eleonore DIWO
    Ophthalmology, DHU ViewMaintain, Pitie Salpetriere Hospital, PARIS, France
  • Adil Darugar
    Ophthalmology, DHU ViewMaintain, Pitie Salpetriere Hospital, PARIS, France
  • Nathalie Massamba
    Ophthalmology, DHU ViewMaintain, Pitie Salpetriere Hospital, PARIS, France
  • Phuc Lehoang
    Ophthalmology, DHU ViewMaintain, Pitie Salpetriere Hospital, PARIS, France
  • Sam Razavi
    Ophthalmology, DHU ViewMaintain, Pitie Salpetriere Hospital, PARIS, France
  • Bahram Bodaghi
    Ophthalmology, DHU ViewMaintain, Pitie Salpetriere Hospital, PARIS, France
  • Footnotes
    Commercial Relationships Eleonore DIWO, None; Adil Darugar, None; Nathalie Massamba, None; Phuc Lehoang, None; Sam Razavi, None; Bahram Bodaghi, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5814. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eleonore DIWO, Adil Darugar, Nathalie Massamba, Phuc Lehoang, Sam Razavi, Bahram Bodaghi; SS- OCT analysis of choroidal involvement in patients with uveitis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5814.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The aim of this clinical case series is to describe the choroid with swept-source OCT (SS-OCT) technology in patients with ocular inflammation and to determine possible signs of infra-clinical reactivation.

Methods: The charts of consecutive patients with intraocular inflammatory disorders, managed between may and june 2013 at Pitie-Salpetriere Hospital, have been reviewed. A choroidal map with SS-OCT, using 12-mm horizontal vertical scans through the macula was performed in all cases.

Results: We included 20 patients with an average age of 55 years (40-84) and a M/F ratio of 0.82. Most of cases were posterior with 7 birdshot retinochoroidopathies (BRC), 3 Behçet's diseases (BD), 2 multifocal choroiditis (MFC), 1 Vogt-Koyanagi-Harada (VKH) disease, 1 acute syphilitic posterior placoid chorioretinitis, 2 ARN syndromes. Four anterior cases were also analyzed. The average choroidal thicknesss (CT) in active and inactive BRC was 280 µm and 247 µm, respectively with a maximum CT decrease of 30 µm immediately after therapeutic initiation. The lowest CT value of 194 µm was found in an advanced atrophic form of BRC associated with a discrete dashed line square. The average retinal thickness (RT) was decreased to 210 µm. CT and RT in 3 BD were decreased to 292 µm and 180 µm. Their low visual acuity was caused by a loss of IS/OS line. CT of the 2 ARN syndromes was decreased to 270 and 210 µm. The maximum CT difference between healthy and affected eyes was 110 µm. In 2 MFC, one patient had an increased CT of 307µm and one patient had a thin CT of 111µm with a minor dashed line square. In the VKH patient CT was unchanged in both eyes. There was a significant asymmetry in the patient with syphilitic placoid chorioretinitis, with a choroidal thickness of 334 µm in the affected eye vs 387 µm in the contralateral eye. CT was increased in a case of sarcoidosic intermediate uveitis while it was normal in cases of anterior uveitis.

Conclusions: Choroidal mapping shows increased CT compared to the controlateral unaffected eye and the same eye after anti-inflammatory treatment as a sign of activity in most cases of this series (BRC, BD or CMF). These cases may have a poor prognosis with further choroidal atrophy. A comparative prospective study of choroidal thickness before and after treatment may complete these preliminary findings.

Keywords: 452 choroid • 550 imaging/image analysis: clinical • 746 uveitis-clinical/animal model  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×